# Role of Enhancing Serotonin Receptors Activity for Sleep Apnea Treatment in Patients With SCI

> **NCT02458469** · PHASE2 · COMPLETED · sponsor: **VA Office of Research and Development** · enrollment: 15 (actual)

## Conditions studied

- Spinal Cord Injury
- Sleep Disordered Breathing

## Interventions

- **DRUG:** Buspirone
- **DRUG:** Trazodone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02458469
- **Lead sponsor:** VA Office of Research and Development
- **Sponsor class:** FED
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-05-14
- **Primary completion:** 2019-04-12
- **Final completion:** 2019-04-12
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2021-06-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02458469

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02458469, "Role of Enhancing Serotonin Receptors Activity for Sleep Apnea Treatment in Patients With SCI". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02458469. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*